Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pegfilgrastim biosimilar by Curateq Biologics for Chemotherapy Induced Neutropenia: Likelihood of Approval
Pegfilgrastim biosimilar is under clinical development by Curateq Biologics and currently in Phase II for Chemotherapy Induced Neutropenia. According to...